Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Acne
(1996): Lee PK+, JAmAcadDermatol34, 855
Acral erythema
(1995): Komamura H+, JDermatol22(2), 116
Acute febrile neutrophilic dermatosis (Sweet’s syndrome)
(2007): Thompson DF+, Ann Pharmacother 41(5), 802
(2006): Hara I+, Int J Urol 13(4), 481
(2006): Oiso N+, Br J Haematol 135(2), 148
(2006): Thompson MA+, Am J Hematol 81(9), 703
(2006): White JM+, Clin Exp Dermatol 31(2), 206 (3 cases)
(2004): Kumar G+, Am J Hematol 76(3), 283
(2002): Brazzelli V+, World Congress Dermatol Poster, 0089
(2001): Magro CM+, JCutanPathol28(2), 90
(2001): Matsumura T+, Br J Haematol 113(1), 1
(2001): Prendiville J+, Pediatr Dermatol 18(5), 417 (2 cases)
(2000): Malone JC+, Arch Dermatol 345 (passim)
(1999): Arbetter KR+, Am J Hematol 61, 126
(1999): Veres K+, Orv Hetil (Hungarian) 140, 1059
(1998): Chao SC+, J Formos Med Assoc 96, 276
(1998): Hasegawa M+, Eur J Dermatol 8, 503 (2 patients)
(1998): Merkel PA, Curr Opin Rheumatol 10, 45
(1996): Garty BZ+, Pediatrics 97, 401
(1996): Jain KK, Cutis 57, 107
(1996): Petit T+, Lancet 347, 690
(1996): Prevost-Blank PL+, JAmAcadDermatol35, 995
(1996): Richard MA+, JAmAcadDermatol35, 629
(1996): Shimizu T+, J Pediatr Hematol Oncol 18, 282
(1995): Shiga Y+, Rinsho Ketsueki (Japanese) 36, 353
(1995): Suzuki Y+, Br J Dermatol 133, 483
(1994): Fukutoku M+, Br J Haematol 86, 645
(1994): Johnson ML+, Arch Dermatol 130, 77
(1994): Reuss-Borst MA+, Leuk Lymphoma 15, 261
(1994): van Kamp H+, Br J Haematol 86, 415
(1993): Paydas S+, Br J Haematol 85, 191
(1992): Karp DL, AnnInternMed117, 875
(1992): Park JW+, AnnInternMed116, 996
(1991): Ross HJ+, Cancer 68, 441
(1990): Morioka N+, JAmAcadDermatol23, 247
(1989): Groopman JE+, NEnglJMed321, 1449
(1989): Kluin-Nelemans JC+, Br J Haematol 73, 419
Adverse effects (sic) (19%)
(2002): De la Rubia J+, J Hematother Stem Cell Res 11(4), 705
(2002): Heuft HG+, Transfusion 42(7), 928
(2001): Kashiwagi H+, Gan To Kagaku Ryoho 28(8), 1105
(1998): Caballero MD+, Haematologica 83(6), 514 (19%)
(1997): Hanauske AR+, Oncology 54(5), 363
(1997): Yano T+, Int J Hematol 66(2), 169
Allergic granulomatous angiitis (Churg–Strauss syndrome)
(2006): Ferran M+, Dermatology. 2006 212(2), 188
Allergic reactions (sic) (19%)
(2003): van der Kolk LE+, Leukemia 17(8), 1658 (19%)
Diaphoresis
(2000): Khoury H+, Bone Marrow Transplant 25, 1197
Edema
(2000): Milkovich G+, Pharmacotherapy 20(12), 1432
Erythema
(2003): Lenczowski JM+, JAmAcadDermatol49(1), 105
(2001): Prendiville J+, Pediatr Dermatol 18(5), 417
(2001): Tomita Y+, Acta Derm Venereol 81(6), 436
(1990): Farmer KL+, Arch Dermatol 126, 1243
(1989): Groopman JE+, NEnglJMed321, 1449
Erythema nodosum
(2005): George S+, Biol Blood Marrow Transplant 11(10), 816
(1994): Nomiyama J+, Am J Hematol 47, 333
Exanthems (5–63%)
(1996): Glass LF+, JAmAcadDermatol34, 455
(1995): McMullin MF+, Clin Rheumatol 14, 204
(1995): Scott GA, Am J Dermatopathol 17, 107
(1994): Sasaki O+, Intern Med 33, 641
GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF) 259
(1993): Samlaska CP+, Arch Dermatol 129, 645
(1993): Yamashita N+, JDermatol20, 473
(1991): Cohen PR+, JAmAcadDermatol25, 734
(1991): Horn TD+, Arch Dermatol 127, 49 (>5%)
(1990): Farmer KL+, Arch Dermatol 126, 1243
(1990): Lazarus H+, Proc Am Soc Clin Oncol 9, 15
(1988): Brandt SJ+, NEnglJMed318, 869 (63%)
Exfoliative dermatitis (10%)
(1988): Brandt SJ+, NEnglJMed318, 869 (10%)
Folliculitis
(1992): Ostlere LS+, Br J Dermatol 127, 193
Graft-versus-host reaction
(2005): Mohty M+, Leukemia 19(4), 500
(2002): Law L+, Int J Hematol 76(4), 360
(2001): Deeg HJ, Int J Hematol 74(1), 26
(2001): Ji S+, Chin Med J (Engl) 114(2), 191
Lichenoid eruption
(2002): Brazzelli V+, World Congress Dermatol Poster, 0089
Linear IgA dermatosis
(1999): Kano Y+, Eur J Dermatol 9, 122
Lupus erythematosus
(2006): Vasiliu IM+, J Rheumatol 33(9), 1878
Neutrophilic eccrine hidradenitis
(1998): Bachmeyer C+, Br J Dermatol 139, 354
Palmar–plantar pustulosis
(2005): Kurokawa I+, Int J Dermatol 44(6), 529
Peripheral edema (1–10%)
Pruritus (1–5%)
(1990): Farmer KL+, Arch Dermatol 126, 1243
(1990): Steward WP+, Int J Cell Cloning 8, 335
(1989): Steward WP+, Br J Cancer 59, 142 (1–5%)
Psoriasis
(2004): Mossner R+, Exp Dermatol 13(6), 340
(2001): Yonei T+, Nihon Kokyuki Gakkai Zasshi 39(6), 438
(1998): Cho SG+, J Korean Med Sci 13, 685
(1997): Feliu J+, J Natl Cancer Inst 89(17), 1315
(1996): Kavanaugh A, Am J Med 101, 567
Pyoderma gangrenosum
(2006): Miall FM+, Br J Haematol 132(1), 115
(2006): White LE+, Skinmed 5(2), 96
(1998): Merkel PA, Curr Opin Rheumatol 10, 45
(1991): Ross HJ+, Cancer 68, 441
Rash (sic) (10%)